Progress toward the development of agents to modulate the cell cycle
โ Scribed by Peter L Toogood
- Book ID
- 104414682
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 101 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1367-5931
No coin nor oath required. For personal study only.
โฆ Synopsis
With taxanes continuing to prove useful in the clinical treatment of cancer, the next generation of antimitotic agents has entered clinical trials. Other mechanisms awaiting proof-of-concept for the treatment of antiproliferative diseases include inhibition of cyclin-dependent kinases (Cdks). Flavopiridol and UCN-01 are continuing in clinical trials, and newer more selective Cdk inhibitors are now entering clinical evaluation.
๐ SIMILAR VOLUMES
1987 ALAN R. LISS. INC 'Upper values represent mean gold particles per fim2 SEM, n = 3 groups of 20 cells each. < 1 colloid gold particle/fim2 was observed over the cytoplasm and extracellular space. Lower values (parenthesis) represent the summed total of gold $CM sorted on the basis of anti-pl05 i
The three cycles of cell division immediately following the formation of the cellular blastoderm during Drosophila embryogenesis display an invariant pattern('?\*). Bursts of transcription of a gene called string are required and sufficient to trigger mitosis at this time during de~elopment(~). The